Response to Brandt, Bednarz-Knoll, Kleinheinz et al
J Natl Cancer Inst
.
2020 Sep 1;112(9):970-971.
doi: 10.1093/jnci/djaa075.
Authors
Anil K Chaturvedi
1
,
Natalia Udaltsova
2
,
Eric A Engels
1
,
Jed A Katzel
2
,
Elizabeth L Yanik
3
,
Hormuzd A Katki
1
,
Mark W Lingen
4
,
Michael J Silverberg
5
Affiliations
1
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
2
Department of Oncology, Kaiser Permanente, San Francisco, CA, USA.
3
Washington University at St. Louis, St. Louis, MO, USA.
4
Department of Pathology, University of Chicago, IL, USA.
5
Division of Research, Kaiser Permanente, Oakland, CA, USA.
PMID:
32483585
PMCID:
PMC7492756
DOI:
10.1093/jnci/djaa075
No abstract available
Publication types
Letter
Comment
MeSH terms
Cohort Studies
Humans
Leukoplakia, Oral*
Mouth Neoplasms*